Got a crazy shred again 3 months after starting daily microneedling
    Microneedling 11/20/2025

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Tretinoin →

    the gold standard retinoid in dermatology that's also helpful for hair regrowth alongside Minoxidil

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1.25mg daily 2-3 years
    💊 Minoxidil (oral) 5% daily 2-3 years
    💧 Tretinoin (topical) 0.015%
    💧 Nizoral (topical) 2x weekly
    💧 Rosemary-mint oil (topical) 2x weekly
    💧 Microneedling (topical) 0.5mm daily 3 months
    💧 Microneedling (topical) 1mm once weekly 3 months
    💊 Creatine (oral) 5g daily
    the tone is 😞 negative with worsened condition results.

    Other terms

    The user experienced hair loss after switching to daily microneedling and stopping tretinoin, while continuing oral finasteride, minoxidil, and other treatments. The consensus suggests daily microneedling is excessive and harmful, recommending less frequent sessions to allow healing.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      A Review of the Treatment of Male Pattern Hair Loss

      research A review of the treatment of male pattern hair loss

      53 citations , February 2020 in “Expert Opinion on Pharmacotherapy”
      This review discusses pharmacologic and non-pharmacologic treatments for androgenetic alopecia, noting that current medications like finasteride and minoxidil can slow hair loss but only partially restore hair growth, with early treatment offering better outcomes.
      Clinical Trials and Hair Loss

      research Clinical Trials and Hair Loss

      1 citations , July 2018 in “Elsevier eBooks”
      This review explores the current treatments for different types of alopecia, emphasizing the need for well-designed clinical trials and highlighting that most therapies are used off-label, as only androgenetic alopecia has FDA-approved drugs.
      A Decade of Progress in Androgenetic Alopecia Management: Emerging Therapies and Multimodal Strategies

      research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies

      December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology”
      This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
      Cosmetic Approach for Men: Dermatological Needs and Treatments

      research Cosmetic Approach for Men

      January 2017 in “Clinical approaches and procedures in cosmetic dermatology”
      This chapter reviews differences in dermatological treatments and conditions between male and female patients, particularly noting the impacts of sex steroids on various skin processes, but presents no new clinical findings.